Journals / The Journal of Pediatric Research / 2017 / Cilt: 4 - Sayı: 1

Association Between Soluble CD40 Ligand and Hypercholesterolemia in Children and Adolescents

Çocuk ve Adölesanlarda Soluble CD40 Ligandı ile Yüksek Kolesterol Düzeylerinin İlişkisi

Pages
1–5
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

But there was no significant correlation between sCD40L and total cholesterol, LDL-cholesterol, HDLcholesterol, very LDL-cholesterol, triglycerides, 8-OHdG, F1+2 (p>0.05).Conclusion: We believe that future prospective studies to determine the increase in the level of sCD40L with a larger sample size of a pediatric population with dyslipidemias may be more helpful in predicting the risk of cardiovascular disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Coronary heart disease is one of the most common causes of death around the world.
📊
Key Findings & Data:In this study, we investigated the effect of soluble CD40 ligand (sCD40L) and clotting activation on children and adolescents with hypercholesterolemia.Materials and Methods: Plasma levels of sCD40L, P-selectin, 8-hydroxy2-deoxyguanosine (8-OHdG), and prothrombin fragment 1+2 [(F) 1+2] were determined in thirty-five hypercholesterolemic patients (20 girls and 15 boys; age, median: 13 years) and forty healthy normocholesterolemic subjects (28 girls and 12 boys; age, median: 13 years).Results: No significant differences were observed between the patient group and controls in terms of age, high-density lipoprotein (HDL) cholesterol, 8-OHdG, F1+2 (p>0.05).
💡
Conclusion & Impact:But there was no significant correlation between sCD40L and total cholesterol, LDL-cholesterol, HDLcholesterol, very LDL-cholesterol, triglycerides, 8-OHdG, F1+2 (p>0.05).Conclusion: We believe that future prospective studies to determine the increase in the level of sCD40L with a larger sample size of a pediatric population with dyslipidemias may be more helpful in predicting the risk of cardiovascular disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Coronary heart disease is one of the most common causes of death around the world. The pathological process of coronary heart disease like atherosclerosis starts in childhood. During this period thrombosis constitutes a high-risk factor. In this study, we investigated the effect of soluble CD40 ligand (sCD40L) and clotting activation on children and adolescents with hypercholesterolemia.Materials and Methods: Plasma levels of sCD40L, P-selectin, 8-hydroxy2-deoxyguanosine (8-OHdG), and prothrombin fragment 1+2 [(F) 1+2] were determined in thirty-five hypercholesterolemic patients (20 girls and 15 boys; age, median: 13 years) and forty healthy normocholesterolemic subjects (28 girls and 12 boys; age, median: 13 years).Results: No significant differences were observed between the patient group and controls in terms of age, high-density lipoprotein (HDL) cholesterol, 8-OHdG, F1+2 (p>0.05). However, there were significant differences between the two groups with respect to total cholesterol, low-density lipoprotein (LDL) cholesterol, very LDL cholesterol, triglycerides, sCD40L and P-selectin (p<0.05), which were higher in the patient group than the controls. A positive correlation was observed between sCD40L and P-selectin (p<0.05) in accordance with the Spearman correlation analysis. The correlation coefficients were 0.735 in the patient group and 0.647 in the control group. But there was no significant correlation between sCD40L and total cholesterol, LDL-cholesterol, HDLcholesterol, very LDL-cholesterol, triglycerides, 8-OHdG, F1+2 (p>0.05).Conclusion: We believe that future prospective studies to determine the increase in the level of sCD40L with a larger sample size of a pediatric population with dyslipidemias may be more helpful in predicting the risk of cardiovascular disease.

Özet

Amaç: Koroner kalp hastalığı tüm dünyadaki ölüm nedenleri arasında önemli bir yere sahiptir. Ateroskleroz gibi koroner kalp hastalığının patolojik süreci çocukluk çağı dönemlerinde başlamakta olup tromboz bu süreçte önemli bir risk faktörüdür. Bu çalışmada hiperkolesterolemili çocuk ve adölesanlarda soluble-CD40 ligand (sCD40L) ile pıhtılaşmayı aktifleştiren faktörlerin etkisi araştırılmıştır. Gereç ve Yöntemler: Plazma sCD40L, P-selektin, 8-hidroksi-2-deoksiguanozin (8-OHdG), protrombin fragmanı 1+2 [(F) 1+2] düzeyleri, 35 hiperkolesterolemili hasta (20 kız ve 15 erkek; yaş ortalaması 13 yıl) ile 40 sağlıklı kontrol (28 kız, 12 erkek; yaş ortalaması 13 yıl) grubunda değerlendirilmiştir. Bulgular: Her iki grup arasında yaş, yüksek dansiteli lipoprotein (HDL) kolesterol, 8-OHdG, F1+2 düzeyleri açısından anlamlı farklılık saptanmamıştır (p>0,05). Ancak toplam kolesterol, düşük dansiteli lipoprotein (LDL) kolesterol, çok LDL kolesterol, trigliserit, sCD40L ve P-selektin değerleri gruplar arasında anlamlı olarak farklı olup tüm bu değerler hasta grupta daha yüksek olarak ölçülmüştür (p 0,005). Sonuç: Daha geniş dislipidemili çocuk popülasyonunda yapılacak çalışmalarla sCD40L düzeyindeki artışların kardiyovasküler hastalık oluşum riskini belirlemede yardımcı olabileceğini düşünmekteyiz.

🔖

Cite This Article

KÜÇÜKÇONGAE, A. Y., EMİNOĞLU, F. T., OKUR, İ., ARAL, L. A., HASANOĞLU, A., TÜMER, L. (2017). Association Between Soluble CD40 Ligand and Hypercholesterolemia in Children and Adolescents. The Journal of Pediatric Research, Cilt: 4 - Sayı: 1, 1–5. https://ajindex.com/articles/363021

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. World Health Organization. Possible developmental early effects of endocrine disrupters on child health. Geneva, World Health Organization. 2012. Accessed from www.who.int/phe/en Last accessed on November 1, 2016
  2. Newbold RR. Developmental exposure to endocrine-disrupting chemicals programs for reproductive tract alterations and obesity later in life. Am J Clin Nutr 2011;94(6 Suppl):1939S-42S
  3. World Health Organization. Children's Health and Environment. WHO Training package for the Health Sector. World Health Organization, Geneva. 2011. Available at www.who.int/ceh Accessed on November 2, 2016
  4. United Nations Environment Programme and World Health Organization. State of the Science of Endocrine Disrupting Chemicals 2012. Summary for Decision-Makers. Geneva, World Health Organization. 2013. Available at www.who.int/phe/en Accessed on November 1, 2016
  5. World Health Organization (WHO). Global assessment of the state-of-the-science of endocrine disruptors. Geneva, WHO, 2002. Available at www.who.int/ipcs/publications/new_issues/ endocrine_disruptors/en/index.html Accessed on April 15, 2014
  6. Amaral Mendes JJ. The endocrine disrupters: a major medical challenge. Food Chem Toxicol 2002;40:781-8
  7. National Institute of Environmental Health Sciences. Child development and environmental toxins. Available at http://www. niehs.nih.gov/health/assets/docs_a_e/child_development_and_ environmental_toxins_508.pdf Accessed on November 2, 2016
  8. Diamanti-Kandarakis E, Bourguignon J, Giudice LC, et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev 2009;30:293-342
  9. Pesticide exposure in children- Policy statement. American Academy of Paediatrics. Paediatrics 2012;130:1757-63
  10. Fleisch AF, Wright RO, Baccarelli AA. Environmental epigenetics: a role ain endocrine disease? J Mol Endocrinol 2012;49:R61-7.